Total IgE and Der p 1 (D1) specific IgE in induced sputum (IS) in patients with allergic and non-allergic asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018
Effect of montelukast administration on serum IL-5 and total IgE levels in asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004
IgE levels in asthmatics and non-asthmatics are affected by different SNPs in FCER1A Source: Annual Congress 2012 - Asthma and the genes: from GWAS to next generation transcriptome analyses Year: 2012
Total serum IgE in children with unmeasurable concentration of specific IgE (<0.35 kiu/l) Source: Eur Respir J 2005; 26: Suppl. 49, 400s Year: 2005
Monitoring free serum IgE in asthma patients treated with omalizumab Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
Mycoplasma pneumoniae infection affects total eosinophil count, the serum level of ECP, and interleukin-5 in atopic childrenSource: Annual Congress 2012 - Airway infections in children: from risk factors to treatment Year: 2012
Treatment with omalizumab (rhuMAb-E25), a monoclonal anti-IgE antibody induces effective changes in subjects with allergic asthma Source: Eur Respir J 2001; 18: Suppl. 33, 37s Year: 2001
Serum tryptase in relation to airway hyperresponsiveness – A population study Source: Annual Congress 2010 - Methods in respiratory epidemiology Year: 2010
PDCD1 PD-1.3 polymorphism is associated with total IgE and IL-4 levels in Russian patients with atopic asthmaSource: Annual Congress 2009 - Inflammation and airways Year: 2009
One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
Increased levels of angiopoietin 1 & 2 in sputum supernatant in smoking asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
SUPPLEMENT: Omalizumab lowers eNO in children with asthma Source: ISSN=ISSN 1810-6841, ISBN=, page=S3 Year: 2005
LATE-BREAKING ABSTRACT: Correlation of serum free light chain immunoglobulins with total IgE and food- and respiratory allergen-specific IgE in serum of allergic subjects Source: International Congress 2014 – Latest insights in airway diseases Year: 2014
Plasma and urinary concentrations of inhaled salmeterol in healthy and persons with asthma – Quantifying a doping limit Source: Annual Congress 2011 - Asthma management and response Year: 2011
Changes of total IgE and specific IgE antibody to dermatophagoides pteronyssinus (Dp) in cured asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 334s Year: 2002
Monitoring free serum IgE in severe asthma patients treated with omalizumab Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Cloned Th cells confer airway obstruction upon antigen challenge in the absence of IgE antibody – a model for nonatopic bronchoconstriction Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009
Monitoring of efficacy of therapy with monoclonal antibodies – Omalizumab – Using the Recovery-ELISA Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Possible impact of serum IgE variability on dose calculation of omalizumab (anti-IgE) Source: Eur Respir J 2004; 24: Suppl. 48, 220s Year: 2004